Undaria pinnatifida improves obesity-related outcomes in association with gut microbiota and metabolomics modulation in high-fat diet-fed mice
- PMID: 33074417
- DOI: 10.1007/s00253-020-10954-9
Undaria pinnatifida improves obesity-related outcomes in association with gut microbiota and metabolomics modulation in high-fat diet-fed mice
Abstract
Dietary fiber has beneficial effects on obesity-related diseases and gut microbiota, contributing a key role in the interaction between dietary metabolism and host metabolism. Our objective was to investigate the cause of the improvement in multiple types of physiological states with seaweed Undaria pinnatifida treatment on high-fat diet-fed mice and to evaluate whether its consequent anti-adiposity and anti-hyperlipidemic effects are associated with gut microbiota and its metabolomics regulation. U. pinnatifida administration in our experiment was shown to significantly decrease high-fat diet-induced body weight gain, as well as epididymal and abdominal adiposity. U. pinnatifida intake also significantly reduced liver weight and serum triacylglycerol accumulation. We also found that improving effects of U. pinnatifida on high-fat diet-induced metabolic dysfunctions were associated with significant increase in specific bacteria, such as Bacteroides acidifaciens and Bacteroides ovatus, as well as metabolites, including short-chain fatty acids and tricarboxylic acid cycle intermediates. Our result provides a cheap dietary strategy to host metabolism improvement and obesity management. KEY POINTS: • U. pinnatifida improved adipose accumulation and lipid metabolism. • B. acidifaciens and B. ovatus contributed to the beneficial effects of U. pinnatifida. • SCFAs and TCA cycle intermediates were critical to the metabolic outcomes. • Our study provides a cheap dietary strategy for obesity management.
Keywords: Adiposity; Gut microbiota; High-fat diet; Hyperlipidemia; Metabolome; Undaria pinnatifida.
References
-
- Anhe FF, Nachbar RT, Varin TV, Vilela V, Dudonne S, Pilon G, Fournier M, Lecours MA, Desjardins Y, Roy D, Levy E, Marette A (2017) A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss. Mol Metab 6(12):1563–1573. https://doi.org/10.1016/j.molmet.2017.10.003 - DOI - PubMed - PMC
-
- Bai L, Gao M, Cheng X, Kang G, Huang H (2020) Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice. Microb Cell Factories 19(1):94. https://doi.org/10.1186/s12934-020-01350-z - DOI
-
- Bell JA, Carslake D, O’Keeffe LM, Frysz M, Howe LD, Hamer M, Wade KH, Timpson NJ, Smith GD (2018) Associations of body mass and fat indexes with cardiometabolic traits. J Am Coll Cardiol 72(24):3142–3154. https://doi.org/10.1016/j.jacc.2018.09.066 - DOI - PubMed - PMC
-
- Bianchi F, Duque ALRF, Saad SMI, Sivieri K (2019) Gut microbiome approaches to treat obesity in humans. Appl Microbiol Biotechnol 103(3):1081–1094. https://doi.org/10.1007/s00253-018-9570-8 - DOI - PubMed
-
- Burney M, Mathew L, Gaikwad A, Nugent EK, Gonzalez AO, Smith JA (2018) Evaluation fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus in combination with anticancer drugs in human cancer orthotopic mouse models. Integr Cancer Ther 17(3):755–761. https://doi.org/10.1177/1534735417740631 - DOI - PubMed
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
